Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-000919
Filing Date
2023-01-12
Accepted
2023-01-12 20:00:10
Documents
1
Period of Report
2023-01-11

Document Format Files

Seq Description Document Type Size
1 form4-01122023_080101.html 4  
1 form4-01122023_080101.xml 4 3360
  Complete submission text file 0001415889-23-000919.txt   4891
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ADOLOR CORP 700 PENNSYLVANIA DR EXTON PA 19341
Business Address
DOUGHERTY MICHAEL R (Reporting) CIK: 0001033516 (see all company filings)

State of Incorp.: PA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 23526939